Thriva’s Post

It's great to see Thriva named in the recent #Sifted100 report highlighting the top startups in the UK and Ireland 🚀 The mention stands testament to our commitment to revolutionising personalised #Healthcare and empowering individuals to take control of their #Wellbeing. It's encouraging to see that the report features many innovative #HealthTech solutions that share our mission of helping people understand their internal #Health, extend their #Healthspan, and stay ahead of chronic diseases. https://lnkd.in/e2i-n8Wf #HealthInnovation | #BloodTesting | #HealthScreening | #Longevity

Thank you Financial Times for featuring MaNaDr in the latest ranking of the Asia-Pacific region's fastest growing companies. Our business strategy revolves around several key principles that differentiate us in the healthcare industry. Rather than solely chasing short-term revenue, we focus on long-term sustainability and value creation. Secondly, we build lasting connections with our patients and doctors based on trust and patient satisfaction. Furthermore, MaNaDr leverages on technology to optimise resource allocation and automation, ensuring that healthcare professionals are deployed efficiently based on patient needs and demand. Overall, our business strategy encompasses a commitment to long-term sustainability, trust-building, strategic decision-making, and the integration of technology. By adhering to these principles, we position ourselves for continued growth, resilience, and the ability to positively impact the lives of our patients and healthcare professionals. https://lnkd.in/g6T_i6ZU #MaNaDr #HealthcareInnovation #PatientCare #HealthTech #DigitalHealth #HealthcareSolutions #FutureofHealthcare

Wondering about the state of Health Tech venture capital in 2023? According to Fierce Healthcare, funding trends are evolving with a focus on quality and innovation. Fewer deals, but potential game-changing solutions from startups. What do you think about this shift? Read more: https://lnkd.in/ezuWMcSt #HealthTech #VentureCapital #Innovation #Startups #FundingTrends

The rise of the unlabelled raise is another new norm for startups in 2023. One of the great takeaways in this article from Fierce Healthcare that discusses the current funding landscape for #DigitalHealth startups. Like other health related sectors, #Fundraising right now in this area is tough, but given the heady heights of recent years there has been a much more dramatic downturn in the investment dollars available. As we kick off the next UMassM2D2 #IMPACT Cohort shortly, looking forward to supporting some of the leading startups in this space. Not only towards their fundraising goals, but more importantly helping build the right relationships that will assist getting these solutions to patients faster. Feel free to get in touch if you think you could provide support to make this happen! https://lnkd.in/eXGR_Djd #Medtech #Startups #KeepInnovating

🔎 State of Digital Health Q2’23 Report, by CB Insights In Q2’23, global #digitalhealth funding slipped for the sixth straight quarter, while deals reached an 8-year low. However, #investors continue to back promising #startups, with Q2 seeing upticks in early-stage deal sizes and mega-round deals. Key takeaways: ✅Global digital health funding and deals fall to their lowest levels in years. ✅#Caredelivery & navigation tech companies lead among categories in both deals and funding. ✅US digital health funding drops to its lowest point since Q3’17. ✅The median deal size for early-stage rounds ticks up. ✅Mega-round funding and deals increase for the first time since Q4’21. Link in the comments. #digitaltherapeutics #digitalbiomarkers #digitalmedicine

#Startups, this brief from Becker's Healthcare summarizes the funding landscape for #digitalhealth for the 3rd quarter of 2023. In this funding climate, the onus is on you to polish your #pitches, articulate #value, and show #clinicalvalidation. #startupsuccess #VCfunding

Health is so fundamental to our quality of life, but healthcare is rife with administrative inefficiencies. Healthcare expenditures are almost 20% of U.S. GDP. Disruption in this space has always been difficult, but gen AI is poised to change the healthcare industry – not just driving efficiency, but dramatically improving patient outcomes. We are excited to meet the innovators driving change in this space.

Value-based care startups are shaking up the health system. Learn more about their momentum and read more of my thoughts in a recent article from Brian Gormley below. 

Excellent article by Omri Amirav-Drory discussing the impact of extending healthspan on individuals and the economy. This insightful piece highlights how enhancing healthspan not only improves lives but also boosts our economy and enhances industries. Check it out: The Business Case for Longevity on nfx.com.